BRFAA - Biomedical Research Foundation Academy Of Athens
Biomedical Research Foundation Academy Of AthensAcademy Of Athens


Emmanouilidou E, Melachroinou K, Garbis S., Ntzouni M., Margaritis L., Stefanis L, Vekrellis K (2010b) Alpha synuclein is secreted via exosomes in a calcium dependent manner. J. Neurosci 30(20):6838-51.

Emmanouilidou E, Stefanis L, Vekrellis K (2010a) Cell-produced alpha-synuclein oligomers are targeted to the 26S proteasome and impair its function. Neurobiol Aging 31(6):953-68.

Vekrellis K, Xilouri M, Emmanouilidou E, Stefanis L (2009) Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death. J Neurochem 109(5):1348-62.

Xilouri M, Vogiatzi T, Park D, Vekrellis K, Stefanis L (2009) Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 4(5):e5515.

Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L (2008) Wild type α-synuclein is degraded by chaperone mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 283(35):23542-56.

Vekrellis K, Zhen Y, Qiu W, Walsh D, Hartley D, Chesnau V, Rosner M, Selkoe DJ (2000) Neurons downregulate extracellular levels of Aβ via proteolysis by Insulin Degrading Enzyme. J Neurosci 20 (5):1657-65.

Vekrellis K, Chesneau V, Rosner MR, Selkoe DJ (2000) Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization. Biochem J 351 (2):509-16.

Vekrellis Lab Related Links